Want to see what we’re working on?
Stay in the loop
For the latest updates as they happen, follow us on LinkedIn.
Introducing our new website!
New look, new features, and more ways to share information.
Driving Change, Delivering Impact
Our 2026–29 strategic plan provides direction for the pCPA’s continued evolution.
One year on the job: Interview with our CEO, Mauro Chies
To celebrate his first year, our CEO reflects on what he’s learned since joining the organization, as well as his plans for the next year and beyond.
pCPA deputy CEO to serve as co-chair of ISPOR roundtable
The pCPA is excited to announce Dominic Tan has been appointed co-chair of the HTA Roundtable at the North American branch of ISPOR.
End-of-year message from Mauro Chies
Reflecting on 2025, a year of big progress and big steps for the pCPA.
Our new expedited negotiation pathways have launched
The pCPA is thrilled to expand its negotiation options with the launch of expedited negotiation pathways are designed to accelerate negotiation timelines.
We’ve developed new negotiation pathways and want your feedback
New and refreshed negotiation processes are now available for review, along with an online survey to gather your feedback.
New negotiation pathways are coming
Our teams are currently working on new approaches to our negotiation processes
Impact report 2024–25: New frontiers
The pCPA’s Board of Directors is pleased to announce the release of our 2024–25 impact report
The pCPA achieves record savings for public drug plans in 2024–25
Our latest dashboard shows we saved public drug plans an estimated $4.9 billion in 2024–25.